Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MIF | P14174 | 1/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.33 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.33 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.32 |
| ▸ | MEN1 | O00255 | 1/20 | 0.32 |
| ▸ | MAPT | P10636 | 1/20 | 0.32 |
| ▸ | HTT | P42858 | 1/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.32 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.32 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.32 |
| ▸ | PKM | P14618 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3786144 | 0.92 | MIF (0.32) | MIF | |
| SCHEMBL3780487 | 0.90 | — | — | |
| SCHEMBL3792322 | 0.81 | MIF (0.41) | MIFALDH1A1TDP1ALOX15MEN1 | |
| SCHEMBL12251471 | 0.77 | MIF (0.37) | MIFALDH1A1TDP1KDM4EALOX15 | |
| SCHEMBL4755288 | 0.75 | MIF (0.42) | MIFALDH1A1TDP1ALOX15MEN1 | |
| SCHEMBL3786393 | 0.72 | MIF (0.34) | MIF | |
| SCHEMBL12251472 | 0.72 | MIF (0.40) | MIFALDH1A1TDP1KDM4EALOX15 | |
| SCHEMBL13649840 | 0.72 | MIF (0.40) | MIFALDH1A1TDP1KDM4EALOX15 | |
| SCHEMBL3785681 | 0.72 | PPM1B (0.30) | — | |
| SCHEMBL1463170 | 0.72 | MIF (0.46) | MIFALDH1A1TDP1ALOX15MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7696366-B2 | Production process of bifunctional epoxy monomer by selective oxidation of diolefin compound | SHOWA DENKO K.K. (JP) | 2010-04-13 | — | — | US | disclosed |
| EP-1891031-B1 | PRODUCTION PROCESS OF BIFUNCTIONAL EPOXY MONOMER BY SELECTIVE OXIDATION OF DIOLEFIN COMPOUND | SHOWA DENKO KK (JP) | 2009-03-11 | — | — | EP | disclosed |
| US-20090030217-A1 | PRODUCTION PROCESS OF BIFUNCTIONAL EPOXY MONOMER BY SELECTIVE OXIDATION OF DIOLEFIN COMPOUND | SHOWA DENKO K.K. (JP) | 2009-01-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090030217-A1 | PRODUCTION PROCESS OF BIFUNCTIONAL EPOXY MONOMER BY SELECTIVE OXIDATION OF DIOLEFIN COMPOUND | DUOX2, DUOX1, DDT | MIF 1324/4885ALDH1A1 747/4885TDP1 4138/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.